Randomized Phase III Trial in Non-Transplant Eligible Patients with Newly Diagnosed Symptomatic Multiple Myeloma Comparing Melphalan-Prednisone-Thalidomide Followed By Thalidomide Maintenance (MPT-T) Versus Melphalan-Prednisone-Lenalidomide Followed By Maintenance with Lenalidomide (MPR-R); A Joint Study of the Dutch-Belgian Cooperative Trial Group for Hematology Oncology (HOVON) and the Nordic Myeloma Study Group (NMSG)

Sonja Zweegman, Bronno van der Holt, Ulf-Henrik Mellqvist, Morten Salomo, Gerard M. J. Bos, Mark-David Levin, Heleen A. Visser-Wisselaar, Markus Hansson, Annette WG van der Velden, Wendy Deenik, Astrid Gruber, Juleon LLM Coenen, Torben Plesner, Saskia K Klein, Bea Tanis, Damian L. Szatkowski, Rolf Brouwer, Matthijs Westerman, BL Leys, Niels W. C. J. van de DonkEinar Haukås, Klaas van der Hem, MF Durian, E (Vera) JM Mattijssen, Harm AM Sinnige, Marian JPL Stevens-Kroef, Pieter Sonneveld, Anders Waage

Publikation: Konferencebidrag uden forlag/tidsskriftKonferenceabstrakt til konferenceForskningpeer review

OriginalsprogEngelsk
Publikationsdato2014
StatusUdgivet - 2014
Begivenhed56th American Society of Hematology Annual Meeting & Exposition - San Fransisco, CA, USA
Varighed: 6. dec. 20149. dec. 2014
Konferencens nummer: 56

Konference

Konference56th American Society of Hematology Annual Meeting & Exposition
Nummer56
LandUSA
BySan Fransisco, CA
Periode06/12/201409/12/2014

Citationsformater

Zweegman, S., van der Holt, B., Mellqvist, U-H., Salomo, M., M. J. Bos, G., Levin, M-D., A. Visser-Wisselaar, H., Hansson, M., WG van der Velden, A., Deenik, W., Gruber, A., LLM Coenen, J., Plesner, T., K Klein, S., Tanis, B., L. Szatkowski, D., Brouwer, R., Westerman, M., Leys, BL., ... Waage, A. (2014). Randomized Phase III Trial in Non-Transplant Eligible Patients with Newly Diagnosed Symptomatic Multiple Myeloma Comparing Melphalan-Prednisone-Thalidomide Followed By Thalidomide Maintenance (MPT-T) Versus Melphalan-Prednisone-Lenalidomide Followed By Maintenance with Lenalidomide (MPR-R); A Joint Study of the Dutch-Belgian Cooperative Trial Group for Hematology Oncology (HOVON) and the Nordic Myeloma Study Group (NMSG). Abstract fra 56th American Society of Hematology Annual Meeting & Exposition, San Fransisco, CA, USA.